Open AccessKaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy
Author(s) -
D’Addona Matteo,
Pezzullo Luca,
Giudice Valentina,
Serio Bianca,
Baldi Carlo,
Zeppa Pio,
Selleri Carmine
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5919
Subject(s) - medicine , myeloid leukemia , imatinib mesylate , sarcoma , imatinib , immunosuppression , myeloid sarcoma , tyrosine kinase inhibitor , dasatinib , leukemia , tyrosine kinase , cancer research , immunology , pathology , cancer , receptor
Kaposi's sarcoma is associated with immunosuppression and human herpesvirus 8 infection, while rarely described in myeloid malignancies. Here, we illustrate a rare case of chronic myeloid leukemia treated with imatinib, a tyrosine kinase inhibitor, who developed a human herpesvirus 8‐related Kaposi's sarcoma.